Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 2
2024 1
2025 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Association of plasma Alzheimer's disease biomarkers with cognitive decline in cognitively unimpaired individuals.
Cogswell PM, Wiste HJ, Therneau TM, Griswold ME, Mattsson-Carlgren N, Palmqvist S, Binette AP, Stomrud E, Bateman RJ, Barthelemy N, Braunstein JB, West T, Verghese PB, Machulda MM, Graff-Radford J, Algeciras-Schimnich A, Lowe VJ, Schwarz CG, Senjem ML, Gunter JL, Knopman DS, Vemuri P, Petersen RC, Hansson O, Jack CR Jr. Cogswell PM, et al. Alzheimers Dement. 2025 Sep;21(9):e70625. doi: 10.1002/alz.70625. Alzheimers Dement. 2025. PMID: 40883967 Free PMC article.
INTRODUCTION: Plasma biomarkers' utility for predicting incident mild cognitive impairment (MCI) remains unclear. ...
INTRODUCTION: Plasma biomarkers' utility for predicting incident mild cognitive impairment (MCI) remains unclear. ...
Association of plasma biomarkers of Alzheimer's pathology and neurodegeneration with gait performance in older adults.
Ali F, Syrjanen JA, Figdore DJ, Kremers WK, Mielke MM, Jack CR, Knopman DS, Vemuri P, Graff-Radford J, Windham BG, Barnard LR, Petersen RC, Algeciras-Schimnich A. Ali F, et al. Commun Med (Lond). 2025 Jan 16;5(1):19. doi: 10.1038/s43856-024-00713-6. Commun Med (Lond). 2025. PMID: 39820537 Free PMC article.
A sample of 2641 Mayo Clinic Study of Aging participants with measurements of plasma biomarkers and gait parameters was analyzed in this cross-sectional study. Linear regression models using plasma biomarkers as predictors of gait parameters and adjust …
A sample of 2641 Mayo Clinic Study of Aging participants with measurements of plasma biomarkers and gait parameters was analyz …
Comparison of plasma biomarkers and amyloid PET for predicting memory decline in cognitively unimpaired individuals.
Jack CR Jr, Wiste HJ, Algeciras-Schimnich A, Weigand SD, Figdore DJ, Lowe VJ, Vemuri P, Graff-Radford J, Ramanan VK, Knopman DS, Mielke MM, Machulda MM, Fields J, Schwarz CG, Cogswell PM, Senjem ML, Therneau TM, Petersen RC. Jack CR Jr, et al. Alzheimers Dement. 2024 Mar;20(3):2143-2154. doi: 10.1002/alz.13651. Epub 2024 Jan 24. Alzheimers Dement. 2024. PMID: 38265198 Free PMC article.
BACKGROUND: We compared the ability of several plasma biomarkers versus amyloid positron emission tomography (PET) to predict rates of memory decline among cognitively unimpaired individuals. ...The outcome was a change in a memory composite measure. RESULTS: All …
BACKGROUND: We compared the ability of several plasma biomarkers versus amyloid positron emission tomography (PET) to predict …
Predicting amyloid PET and tau PET stages with plasma biomarkers.
Jack CR, Wiste HJ, Algeciras-Schimnich A, Figdore DJ, Schwarz CG, Lowe VJ, Ramanan VK, Vemuri P, Mielke MM, Knopman DS, Graff-Radford J, Boeve BF, Kantarci K, Cogswell PM, Senjem ML, Gunter JL, Therneau TM, Petersen RC. Jack CR, et al. Brain. 2023 May 2;146(5):2029-2044. doi: 10.1093/brain/awad042. Brain. 2023. PMID: 36789483 Free PMC article.
Disease staging with amyloid and tau PET has face validity; however, this would be more practical with plasma biomarkers. Our objectives were, first, to examine approaches for staging amyloid and tau PET and, second, to examine prediction of amyloid and tau PET stag …
Disease staging with amyloid and tau PET has face validity; however, this would be more practical with plasma biomarkers. Our …